MCP-1とCCR2のポリモルフィズムにより,個別化されたリスク評価への道を開く
Foddha Hajer1, Saoud Hana2, Bouzidi Nadia1
1Laboratory of Human Genome and Multifactorial Diseases (LR12ES07), Faculty of Pharmacy, University of Monastir, Tunisia.
Human immunology
|August 23, 2025
まとめ
MCP-1 と CCR2 の遺伝的変異は冠動脈疾患 (CAD) のリスクと重症度に影響します. MCP-1-2518GアレルはCADの感受性を高め,CCR2-V64I変異体はその重症性を低下させる可能性があります.
科学分野:
- 免疫遺伝学
- 心血管疾患の研究
- 分子生物学
背景:
- ケモカインと受容体は,動脈硬化と冠動脈疾患 (CAD) の病原性において極めて重要です.
- これらの分子の遺伝的変異は,疾患の発達と進行に影響を与える可能性があります.
研究 の 目的:
- MCP-1 (単細胞化学吸引タンパク質-1) とCCR2ポリモルフィズムとCADの感受性および重症性の関連性を調査する.
- チュニジアの集団でMCP-1-2518A/G (rs1024611),MCP-1-362G/C (rs2857656) とCCR2-V64I (rs1799864) を評価する.
主な方法:
- 200人のCAD患者と102人の健康な対照群でのケース・コントロール研究.
- CADの確認のための冠動脈血管図と重症度の評価のためのゲンシニスコア.
- ポリメラーゼ連鎖反応 (PCR) と制限断片長ポリモルフィズム (RFLP) 解析を用いた遺伝子型決定
主要な成果:
- MCP- 1 - 2518Gアレルは,特に心筋梗塞,肥満,または脂質不全の患者で,CADのリスクの増加 (p=0. 02) と有意に関連していました.
- CCR2- V64I変異は,特に非喫煙者および肥満や脂質不全症のない人では,CADの重度が低下したとの関連を示した.
結論:
- MCP-1-2518A/GとCCR2-V64Iのポリモルフィズムは,CADの感受性と重症性の遺伝子マーカーとして作用する可能性があります.
- これらの発見は,CAD管理におけるリスク層分化とパーソナライズされた治療戦略の強化の可能性を示唆しています.
さらに関連する動画
関連する概念動画
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Human Genetics
719
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
719
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Single Nucleotide Polymorphisms-SNPs
15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K


